ClinicalTrials.Veeva

Menu

Observational Study of Oxygen Delivery During a Fractional Fluid Expansion (OR)

C

Caen University Hospital

Status

Completed

Conditions

Impaired Oxygen Delivery
Hypovolemia
Cardiac Output, Low

Treatments

Drug: hydroxyethylstarch 130/0.4

Study type

Observational

Funder types

Other

Identifiers

NCT01826253
A12-D37-VOL.13

Details and patient eligibility

About

Fluid expansion during cardiocirculatory insufficiency was helped by cardiac output monitoring. However, the goal of fluid expansion was to increase the oxygen delivery, which consider cardiac output, but also Haemoglobin which decrease during a fluid challenge. The maximalization of cardiac output could decrease the oxygen delivery if the haemodilution was too wide. The aim of this study was to describe the oxygen delivery during a fluid expansion conducted for cardiac output maximalization, following actual guidelines.

Full description

One group of 20 anticipated patients

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults over 18 years
  • Patients in intensive care after cardiac surgery under mechanically ventilation and with oesophageal Doppler

Exclusion criteria

  • Arrythmia
  • Pregnancy or childrens
  • Patients without cardiac output monitoring with oesophageal Doppler
  • Patients without medical indication for fluid expansion
  • Urgency surgery

Trial design

20 participants in 1 patient group

Hypovolemia
Description:
Fluid expansion
Treatment:
Drug: hydroxyethylstarch 130/0.4

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems